The current standard for a celiac disease diagnosis is a positive blood test for specific antibodies, followed by a biopsy of the intestine that reveals damage to the villi (villous atrophy). These tests are certainly invasive and unpleasant, but more than that, they are useless in cases where a patient is already following a gluten-free diet. These patients must then undergo a “gluten challenge” of up to eight weeks, during which time they reintroduce gluten-containing foods into their diet, and suffer the consequences. Only then will the blood test and biopsy accurately reveal the hallmarks necessary for an accurate diagnosis.
1/11/2018
New Testing Option for Possible Celiac Disease Sufferers
Recent Posts
- A New Study Sheds Light On The Economic Burden Of Celiac Disease Beyond The Gluten-Free Diet
- Join Us! Celiac Disease Foundation Congressional District Days 2024 Campaign
- New Study: Ethnic Minorities with Celiac Disease Face Higher Healthcare Needs and Nutrient Deficiencies
- A Promising New Approach from Chugai Pharmaceuticals for Blocking Gluten-Induced Immune Response in Celiac Disease
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Research News
- Research Press
- Trending Topics
Marilyn's Message
5/1/2024
Read moreRevolutionizing Celiac Disease Diagnosis – Marilyn’s Message May 2024
Celiac Disease Foundation CEO Joins a Study Developing a Breakthrough Screening Tool The Celiac Disease Foundation asks patient families to participate in research every single day. Why? Because joining research studies and clinical trials is the only way to help scientists better understand this autoimmune disease and ultimately find a...